Accéder au contenu
Merck

Radiolabeling of fibrinogen using the iodogen technique.

Thrombosis and haemostasis (1981-10-01)
L C Knight, A Z Budzynski, S A Olexa
RÉSUMÉ

The properties of human fibrinogen labeled with 125-Iodine using Iodogen (1, 3, 4, 6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril) as an oxidizing agent were compared with those of an iodine monochloride labeled counterpart. It was found that thrombin clottability, binding to staphylococci, the relative specific radioactivity of the A alpha, B beta, and gamma chains and in vivo clearance from plasma in rabbits were the same in these two labeled fibrinogen preparations. Labeling efficiency was higher when iodogen was used. It is concluded that human fibrinogen labeled with radioiodine using the Iodogen technique is suitable for studies in vitro and in vivo.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Iodine monochloride, reagent grade, ≥95%
Sigma-Aldrich
Iodine monochloride solution, 1.0 M in methylene chloride
Sigma-Aldrich
Iodine monochloride, ACS reagent, 1.10±0.1 I/Cl ratio basis
Sigma-Aldrich
Iodine monochloride solution, 1 M in acetic acid
Sigma-Aldrich
Iodine monochloride, 99.998% trace metals basis